Autorisation d’accès précoce refusée à la spécialité EMCITATE (tiratricol) dans l'indication « traitement de la thyrotoxicose périphérique chez les patients atteints d’un déficit en transporteur 8 de monocarboxylate (MCT8) (syndrome d’Allan-Herndon-Dudley), dès la naissance. »
See also
HAS opinions and decisions
07/08/2025
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
UtHCpj0nGrkaE1gS
Listen
